Product Detail
RINVOQ-Upadacitinib Sustained-release Tablets
Detailed inquiry page for product identification, sourcing review, document preparation, and shipment planning.
Inquiry review onlyNo online sale impliedDocument check required
Product Review Summary
1
CategoryImmunology & Inflammation
2
Inquiry TypePrescription medicine sourcing review
3
AvailabilityConfirmed after destination and document review
Product Information
Identification details
| Product Name | RINVOQ-Upadacitinib Sustained-release Tablets |
|---|---|
| Therapeutic / Supply Category | Immunology & Inflammation |
| Trade Name | RINVOQ |
| Generic Name | Upadacitinib Sustained-release Tablets |
| Strength / Pack Size | 30mg* 28Tablets/box/pack |
| Manufacturer | AbbVie Ireland NL B.V.(Ireland) |
| MA Holder | AbbVie Deutschland GmbH & Co. KG(Germany) |
| Approval / Registration | HJ20220010/HJ20220011 |
Inquiry Requirements
What MEDIHALL needs to review this product
Product matchConfirm brand/generic name, dosage form, strength, package size, and target quantity.
Destination and purposeShare destination country, consignee type, project purpose, and target timeline.
Document checklistTell us whether invoice, packing list, certificate, registration, customs, or buyer-specific documents are needed.
Handling conditionsConfirm cold-chain, shelf-life, storage, urgency, and shipment handover requirements.
Availability reviewMEDIHALL reviews supply feasibility after product and destination details are clear.
Compliance noteProduct listing does not guarantee availability and does not imply direct online sale.
Related Products
Similar inquiry items
Inquiry
Ask MEDIHALL to review RINVOQ-Upadacitinib Sustained-release Tablets
Send product details, destination country, quantity, timeline, and document requirements for review.
Email:
Phone: